Abveris, Saccharo partner on antibody discovery

By The Science Advisory Board staff writers

December 3, 2020 -- Abveris has entered into an antibody discovery partnership with Saccharo for the discovery of monoclonal antibodies to advance Saccharo's immuno-oncology therapeutic pipeline.

Under the agreement, Abveris will utilize its DiversimAb mouse model in combination with its next-generation B-cell screening platform (powered by Berkeley Lights Beacon) to rapidly discover monoclonal antibodies. In return for its services, Abveris will receive compensation partially in the form of equity.

Abveris, Immunitas partner on mAbs discovery
Abveris and Immunitas Therapeutics are partnering on the discovery of monoclonal antibodies (mAbs) to expand Immunitas' therapeutic pipeline.

Copyright © 2020 scienceboard.net

International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter